NPI registry status
Active
2026 NPPES data Urology Physician NPI 1720041981 M.D.
Verify on CMS → Paul Russinko, M.D.
Urology Physician in Lancaster, Pennsylvania.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 13,606 in Urology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 619 beneficiaries · Urology Physician avg: 1K
Generic prescribing
89%
generic claims · 11% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$509.48
27 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Paul Russinko, M.D. filed 2,165 Medicare Part D claims in 2024 as a Urology Physician in Lancaster, Pennsylvania, prescribing 89% generic.
- 2K
- Part D claims, 2024
- 89%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥85th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Paul Russinko, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1720041981), first enumerated 04/10/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 2,165 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$509.48 in reported industry payments (27 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Pennsylvania statewide board action statistics are published annually — these figures describe aggregate state activity, not Paul Russinko, M.D.'s individual license status. Verify directly with the state medical board.
Source: PA-BOM annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1720041981 · Urology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · RX-MID · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1720041981
- ENUM-LEGACY 2006
- TAX-MID 14K Urology Physician
- RX-MID 2,165
- BOOK-LIGHT 613 in Pennsylvania
- PHOTO-ENUM Manmohan Gursahani, MD · 2006
Paul Russinko, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
2,165 ≥ 85th percentile 85% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Paul Russinko, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Paul Russinko, M.D.?
Quality data not reportedPrimary specialty
Urology Physician
Medicare Part D claims
2,165 60% vs specialty avg
Specialty distribution in Pennsylvania
How Urology Physician compares to other specialties among Pennsylvania providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Urology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1720041981 |
|---|---|
| Specialty | Urology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 04/10/2006 |
Hospital and facility affiliations
Facilities where Paul Russinko, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
The Centers For Advanced Urology LLP
Lancaster, PA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Paul Russinko, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$509
Largest payer
UROGEN PHARMA, INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Pennsylvania PA-BOM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 - they are NOT specific to Paul Russinko, M.D.. To verify Paul Russinko, M.D.'s current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases
PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Paul Russinko, M.D. - brand share 11.0%
Urology Physician average
11% brand-name claims vs 89% generic, on 2,165 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
2,165
Total Claims
$275K
Total Drug Cost
619
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 4,936.133
- Total Day Supply
- 137,903
- Brand vs Generic
- 11% brand / 89% generic
- Brand Drug Cost
- $227K
- Generic Drug Cost
- $48K
- Opioid Claims
- 91 (4.2% rate)
- Antibiotic Claims
- 217
Patient Demographics
- Average Patient Age
- 75.3 years
- Avg HCC Risk Score
- 1.36
- Gender Split
- 12% female / 88% male
- Age Distribution
- <65: 21, 65-74: 271, 75-84: 263, 85+: 64
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Paul Russinko, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Finasteride
Finasteride
422 claims
- Alfuzosin Hcl Er
Alfuzosin Hcl Er
351 claims
- Tamsulosin Hcl
Tamsulosin Hcl
348 claims
- Myrbetriq 153
Myrbetriq
153 claims
- Dutasteride 126
Dutasteride
126 claims
- Levofloxacin 79
Levofloxacin
79 claims
- Sulfamethoxazole-T… 61
Sulfamethoxazole-Trimethoprim
61 claims
- Solifenacin Succin… 44
Solifenacin Succinate
44 claims
| Drug | Claims |
|---|---|
| Finasteride | 422 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 351 |
| Tamsulosin Hcl | 348 |
| Myrbetriq Mirabegron | 153 |
| Dutasteride | 126 |
| Levofloxacin | 79 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 61 |
| Solifenacin Succinate | 44 |
| Oxycodone Hcl | 43 |
| Trospium Chloride | 42 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Urology Physician Overview
How Paul Russinko, M.D. fits within the Urology Physician landscape nationally.
13,606
Urology Physician Providers in US
54
States with Urology Physician
1,354
Avg Claims per Provider
Paul Russinko, M.D.'s 2,165 claims are above the specialty average of 1,354.
Nationwide Urology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Russinko, both outside Pennsylvania so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Urology Physician Providers in Pennsylvania
Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as Russinko.
One of 613 Urology Physician providers enrolled in Pennsylvania, 5 are shown here.
Ahmed Abdalla
Philadelphia, PA
Dr. Vineet Agrawal
M.D.
Sayre, PA
Dr. Victor Agusta
MD
Lancaster, PA
Dr. Max Ahn
M.D.
Wynnewood, PA
Dr. Saeed Akbari
M.D.
Coudersport, PA
Compare Urology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Paul Russinko, M.D.'s specialty? ▼
Paul Russinko, M.D. specializes in Urology Physician and practices in Lancaster, Pennsylvania. Credentials: M.D..
How much does Paul Russinko, M.D. prescribe under Medicare Part D? ▼
In 2024, Paul Russinko, M.D. wrote 2,165 Medicare Part D claims totaling $275K in drug costs for 619 beneficiaries.
Where is Paul Russinko, M.D. located? ▼
Paul Russinko, M.D. is located at 2106 HARRISBURG PIKE, Lancaster, PA, 17601. Phone: (717) 393-1771.
What is Paul Russinko, M.D.'s NPI number? ▼
Paul Russinko, M.D.'s National Provider Identifier (NPI) is 1720041981, issued on 04/10/2006.
Does Paul Russinko, M.D. prescribe more brand-name or generic drugs? ▼
Paul Russinko, M.D.'s prescribing is 11% brand-name and 89% generic drugs by claim count, with $227K in brand drug costs.
Does Paul Russinko, M.D. prescribe opioids? ▼
Yes, Paul Russinko, M.D. had 91 opioid claims in 2024 with an opioid prescribing rate of 4.2%.
How many Urology Physician providers are there in the US? ▼
There are 13,606 Urology Physician providers across 54 states in the US. The average Urology Physician provider writes 1,354 Medicare Part D claims per year.
What drugs does Paul Russinko, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Paul Russinko, M.D.'s most frequently prescribed drugs include Finasteride, Alfuzosin Hcl Er, Tamsulosin Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Paul Russinko, M.D. accept Medicare? ▼
Paul Russinko, M.D. appears in CMS Medicare data with 2,165 Part D claims and 619 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Paul Russinko, M.D.'s credentials? ▼
Paul Russinko, M.D.'s NPI is 1720041981 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.